期刊文献+

磷霉素与替考拉宁对90株革兰阳性球菌的联合药敏研究 被引量:11

Antibacterial Activity of Fosfomycin Combined with Teicoplanin Against Gram-positive Cocci
下载PDF
导出
摘要 目的 评价磷霉素与替考拉宁对 90株革兰阳性 ( G+)球菌的体外联合抗菌效应。方法 采用棋盘法设计 ,微量肉汤稀释法测定 ;测定不同浓度组合的抗菌药物对 90株临床分离的革兰阳性球菌的联合药敏 ,计算 FIC指数并判定联合效应 ;FIC≤ 0 .5为协同作用 ,0 .5 <FIC≤ 1为相加作用 ,1<FIC≤ 2为无关作用 ,FIC>2为拮抗作用。结果 磷霉素与替考拉宁联合应用后 ,其 MIC50 显著降低 ;FIC指数分布 :FIC≤ 0 .5占 6 0 .0 0 %~ 93.30 % ;0 .5 <FIC≤ 1占 6 .70 %~ 4 0 .0 0 % ;1<FIC≤ 2为 0 ;FIC>2为 0。结论 磷霉素与替考拉宁联合用药后 ,对革兰阳性球菌基本表现为协同作用和相加作用 ,并以协同作用为主 ,无关作用较少 。 OBJECTIVE To evaluate the antibiotic effects of fosfomycin combined with teicoplanin against 90 strains of Grams positive cocci. METHODS The protocol was designed by checkboard method and the MICs of fosfomycin alone and combined with teicoplanin against the 90 strains of Gram positive cocci were determined by broth dilution method, the FIC index was calculated according to MIC results. RESULTS The MIC 50 of fosfomycin were reduced significantly when combined with vancomycin. The percentage of the FIC index less than 0.5, from 0.5 to 1, from 1 to 2, more than 2 was 60.00-93.30%, 6.70-40.00%, 0, and 0, respectively. CONCLUSIONS The results suggested that synergism and additivity of fosfomycin combined with teicoplanin against 90 strains of Gram positive cocci be the main actions, there are the little autonomy and no antagonism.
作者 裴斐 王睿
机构地区 解放军总医院
出处 《中华医院感染学杂志》 CAS CSCD 2004年第11期1282-1284,共3页 Chinese Journal of Nosocomiology
关键词 磷霉素 万古霉素 革兰阳性球菌 联合药敏 Fosfomycin Teicoplanin Gram-positive cocci FIC
  • 相关文献

参考文献8

  • 1[1]Sahm DF, Washington JA Ⅱ. Antibacterial susceptibility tests: dilution methods[A]. Manual of clinical microbiology[M]. 6th ed. 1995. 1117.
  • 2[2]Eliopoulos GM, Moellering RC Jr. Antimicrobial combinations[A]. Antibootics in Laboratory Medicine[M]. 4th ed. 1996. 330.
  • 3李胜利,张婴元,吴菊芳,周乐,汪复.葡萄球菌医院感染的调查研究[J].中华医院感染学杂志,1998,8(2):65-67. 被引量:139
  • 4黄加权,李小丹,杨慧,陈如,刘守桂,齐俊英,张东绅.耐甲氧西林金黄色葡萄球菌的耐药性研究[J].同济医科大学学报,2000,29(3):264-267. 被引量:7
  • 5张扣兴,唐英春,张天托,饶宪,毕筱刚.医院内感染肠球菌药物敏感性的检测[J].中国抗生素杂志,2000,25(6):440-442. 被引量:18
  • 6[6]Boger DL. Vancomycin, teicoplanin and ramoplanin: synthetic and mechanistic studies[J]. Med Res Rev, 2001, 21(5): 356-381.
  • 7[7]Wood MJ. Comparative safety of teicoplanin and vancomycin[J]. J Chemother, 2000, 12(Suppl5): 21-25.
  • 8[8]Morio A, Miyamoto H, Yamazaki A, et al. A case of primary lung cancer complicated with post-operative intractable pulmonary fistula[J]. Kyobu Geka, 2000, 53(13): 1144-1147.

二级参考文献8

共引文献154

同被引文献58

引证文献11

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部